A randomized controlled clinical trial of intranasal versus subcutaneous midazolam for agitation in terminal illness (MinTU study).
Saved in:
| Title: | A randomized controlled clinical trial of intranasal versus subcutaneous midazolam for agitation in terminal illness (MinTU study). |
|---|---|
| Authors: | Hirschinger H; 3rd Department of Medicine, Medical Faculty Mannheim, University of Heidelberg, University Medical Center Mannheim, Mannheim, Germany.; Pharmacy, Mannheim University Hospital, Mannheim, Germany., Rémi C; Hospital Pharmacy and Department of Palliative Medicine, LMU University Hospital, LMU Munich, Munich, Germany., Jäger E; Institute for Clinical Chemistry, Medical Faculty Mannheim, University of Heidelberg, University Medical Center Mannheim, Mannheim, Germany., Nittka S; Institute for Clinical Chemistry, Medical Faculty Mannheim, University of Heidelberg, University Medical Center Mannheim, Mannheim, Germany., Hetjens S; Department of Medical Statistics, Biomathematics and Information Processing, University of Heidelberg, University Medical Center Mannheim, Mannheim, Germany., Saussele S; 3rd Department of Medicine, Medical Faculty Mannheim, University of Heidelberg, University Medical Center Mannheim, Mannheim, Germany., Merx K; 3rd Department of Medicine, Medical Faculty Mannheim, University of Heidelberg, University Medical Center Mannheim, Mannheim, Germany., Koch J; 3rd Department of Medicine, Medical Faculty Mannheim, University of Heidelberg, University Medical Center Mannheim, Mannheim, Germany., Abba M; 3rd Department of Medicine, Medical Faculty Mannheim, University of Heidelberg, University Medical Center Mannheim, Mannheim, Germany., Ghazal M; 3rd Department of Medicine, Medical Faculty Mannheim, University of Heidelberg, University Medical Center Mannheim, Mannheim, Germany., Hofheinz RD; 3rd Department of Medicine, Medical Faculty Mannheim, University of Heidelberg, University Medical Center Mannheim, Mannheim, Germany., Michaeli T; 3rd Department of Medicine, Medical Faculty Mannheim, University of Heidelberg, University Medical Center Mannheim, Mannheim, Germany., Sperk E; 3rd Department of Medicine, Medical Faculty Mannheim, University of Heidelberg, University Medical Center Mannheim, Mannheim, Germany., Kohlbrenner K; 3rd Department of Medicine, Medical Faculty Mannheim, University of Heidelberg, University Medical Center Mannheim, Mannheim, Germany., Hofmann WK; 3rd Department of Medicine, Medical Faculty Mannheim, University of Heidelberg, University Medical Center Mannheim, Mannheim, Germany., Gencer D; Oeschelbronn Clinic, Centre for Integrative Oncology, Pain and Palliative Medicine, Oeschelbronn, Germany., Boch T; 3rd Department of Medicine, Medical Faculty Mannheim, University of Heidelberg, University Medical Center Mannheim, Mannheim, Germany. |
| Source: | Palliative medicine [Palliat Med] 2026 Jun; Vol. 40 (6), pp. 856-867. Date of Electronic Publication: 2026 Mar 22. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Comparative Study |
| Journal Info: | Publisher: SAGE Publications Country of Publication: England NLM ID: 8704926 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-030X (Electronic) Linking ISSN: 02692163 NLM ISO Abbreviation: Palliat Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1477-030X |
|---|---|
| DOI: | 10.1177/02692163261428947 |
